申请人:Neurocrine Biosciences, Inc.
公开号:US20030114455A1
公开(公告)日:2003-06-19
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:
1
wherein R
1
, R
2
, R
3a
, R
3b
, R
4
, R
5
, and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
本发明披露了GnRH受体拮抗剂,其在治疗男性和女性的各种性激素相关疾病方面具有用途。本发明的化合物具有以下结构:其中R1、R2、R3a、R3b、R4、R5和n的定义如本文所述,包括立体异构体、前药和其药学上可接受的盐。此外,本发明还披露了含有本发明化合物与药学上可接受的载体结合的组合物,以及与拮抗性促性腺激素释放激素有关的使用方法,用于需要这种方法的受体。